We use cookies. Find out more about it here. By continuing to browse this site you are agreeing to our use of cookies.
#alert
Back to search results
New

Director, Global New Product Commercialization

Alnylam Pharmaceuticals
paid time off
United States, Massachusetts, Cambridge
675 West Kendall Street (Show on map)
Feb 19, 2026
Overview

We are seeking a strategic, forward-thinking leader to join our team in a newly created Product Planning role. This individual will play a critical role in shaping the long-term commercial vision of our pipeline assets-integrating deep market insight, competitive intelligence, clinical understanding, and patient-centric thinking to inform development strategy and maximize global impact. The ideal candidate thrives at the intersection of science and strategy, brings a strong track record of cross-functional leadership, and is energized by the opportunity to help build innovative medicines from early development through launch readiness.

Key Responsibilities

  • Formulate early commercial strategy and approach for select pipeline programs; Develop target product profiles, serve as commercial voice for the asset in key governance forums
  • Provide commercial input and strategic guidance to program teams to inform key business decisions on early-stage clinical programs.
  • Collaborate cross-functionally to conduct rigorous market assessments on key disease areas to inform preclinical strategic planning.
  • Understand and communicate requirements for reimbursement and differentiation to ensure successful global commercialization of pipeline assets.
  • Identify gaps in internal understanding of target diseases and create detailed plans to address gaps through KOL engagement and primary market research.
  • Inform the development of forecast assumptions for financial models.

Qualifications

  • Bachelor's Degree in Life Sciences or equivalent required, MBA preferred
  • Minimum 8 years of experience inclusive of market analytics, new product planning and global brand marketing
  • Experience in at least one of ALNY's disease areas of focus (CNS, Hematology, Cardiovascular) preferred, Obesity experience required.
  • Experience working cross-functionally, including collaboration with and influencing of program development team.
  • Solid understanding of pharmaceutical development path and ability to identify operational choices that could impact commercialization.
  • Ability to synthesize findings and clearly articulate implications from multiple sources of information, including primary and secondary market research and data, and formulate strong, supportable recommendations.
  • Strong analytical skills, including the ability to forecast.
  • Aptitude for understanding scientific concepts related to research and development.
  • Strong oral and written communication and presentation skills

#LI-ST1

U.S. Pay Range

$208,300.00 - $281,800.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

AboutAlnylam

We are the leader in RNAi therapeutics- a revolutionaryapproach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possibleand are just at the beginning of what's possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, wherean authentic, inclusive culture and breakthrough thinkingfuel one another.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.

>
Applied = 0

(web-54bd5f4dd9-dz8tw)